Pfizer said that early results from its coronavirus vaccine trial had suggested the vaccine could be as much as 90% effective, the New York Times reported.
Pfizer said that early results from its coronavirus vaccine trial had suggested the vaccine could be as much as 90% effective, the New York Times reported.